<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03325504</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHOUNION</org_study_id>
    <secondary_id>2015-000431-32</secondary_id>
    <secondary_id>EUCTR2015-000431-32-ES</secondary_id>
    <nct_id>NCT03325504</nct_id>
  </id_info>
  <brief_title>A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union</brief_title>
  <acronym>ORTHOUNION</acronym>
  <official_title>A Multi-centre, Open-label, Randomized, Comparative Clinical Trial of Two Doses of Bone Marrow Autologous MSC+ Biomaterial vs Iliac Crest Autologous Graft, for Bone Healing in Non-union After Long Bone Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Autonoma de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Autonoma de Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ORTHOUNION is a multi-centre, open, comparative, randomized, clinical trial with three
      parallel arms that aims to compare the efficacy of three treatments to enhance bone healing
      in patients with long bone non-union.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bone injuries represent an important world medical problem producing significant healthcare
      and societal expenditure. While most bone injuries are not severe and are capable of healing
      through bone regeneration by natural callus formation with standard treatments, severe bone
      injuries may not heal, becoming an important unmet clinical need.

      Non-unions, or pseudarthrosis, may occur in 5% to 20% of long-bone fractures that fail to
      heal properly after more than 6 months, with morbidity, prolonged hospitalization, and
      increased expenses. The most commonly accepted standard augmentation to procure fracture and
      non-union healing consists of autologous bone grafting, obtained from the same patient in a
      different surgical site and transplanted to the reconstruction site. However, autologous bone
      grafting has some drawbacks (such as persistent pain, scar, late recovery, limited amount of
      bone, etc) and a limited regeneration efficacy (success rate of about 74%) and high societal
      cost. Culture-expanded autologous MSCs combined with biphasic calcium phosphate (BCP)
      biomaterial granules have been claimed as a solid regenerative medicine alternative to
      autologous bone grafting in non-unions, although current data are limited. In this context,
      the ORTHOUNION initiative focuses on the opportunity to test the hypothesis of superiority of
      MSC, the investigational ATMP, versus the currently accepted standard therapy, iliac crest
      bone autograft to biologically augment surgical treatment of long-bone non-unions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 5, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone consolidation</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>The percentage of bone consolidation in the comparator treatment arm ( iliac crest autograft) and experimental treatment arm (mesenchymal cells).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone consolidation</measure>
    <time_frame>6 and 24 months</time_frame>
    <description>To compare bone consolidation between the experimental arms and the comparator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological Bone consolidation</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>To compare bone consolidation, using the REBORNE scale, between the experimental arms and the comparator.
The REBORNE scale is an ad-hoc and validated scale, developed by Gomez Barrena et al. (article currently under preparation) as a modification of the RUST score (Whelan, 2010; Journal of Trauma). In the REBORNE scale, the presence/absence of radiological consolidation is evaluated on a total of 4 cortices. Score range from 0 (no bone callus visible) to 4 (callus present with same density as cortical). The total score will be recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Pain</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>To compare level of pain (by Numeric Rating Scale [NSR]) between the experimental arms and the comparator.
The NRS is a scale that rates the patient´s pain from 0-10 (0= no pain, 10= worst pain), at the time of the visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>To compare the rate of complications between the experimental arms and the comparator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health status</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>To compare the health status (by using the Short Form-36 Health Questionnarie) between treatment arms.
The SF-36 questionnaire is a validated, widely used patient-reported health survey which measures their physical and mental health status. It consists of 36 questions organized in 8 dimensions. The total score will be recorded.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Non Union Fracture</condition>
  <arm_group>
    <arm_group_label>hBM-MSCs-Low Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Autologous Cultured Mesenchymal Stem Cells +Biomaterial (Low Dose): 100x106 cells</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hBM-MSCs-High Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Autologous Cultured Mesenchymal Stem Cells+Biomaterial (High Dose): 200x106 cells</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Autologous Illiac crest graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Autologous Iliac Crest Grafting</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cultured Mesenchymal Stem Cells</intervention_name>
    <description>Cultured Mesenchymal Stem Cells obtained from expanded bone marrow</description>
    <arm_group_label>hBM-MSCs-High Dose</arm_group_label>
    <arm_group_label>hBM-MSCs-Low Dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Autologous iliac crest graft</intervention_name>
    <description>Autologous iliac crest grafting</description>
    <arm_group_label>Autologous Illiac crest graft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 years and older, both sexes

          2. Traumatic isolated closed or open Gustilo I and II, IIIA and IIIB humerus, tibial or
             femur diaphyseal or metaphysodiaphyseal fracture with a status of atrophic,
             oligotrophic or normotrophic non-union.

          3. Able to understand, accept and sign informed consent

          4. Medical health coverage

          5. Able to understand and accept the study constraints

        Exclusion Criteria:

          1. Hypertrophic non-unions

          2. Segmental bone loss requiring specific therapy (bone transport, vascularized graft,
             large structural allograft, megaprosthesis, etc)

          3. Unrecovered vascular or neural injury

          4. Other fractures causing interference with weight bearing

          5. Visceral injuries or diseases interfering with callus formation (severe
             cranioencephalic trauma, etc.)

          6. Active infection of any location and aetiology

          7. Surgical contraindication of any cause

          8. Pregnancy, breast feeding women and women who are of childbearing age and not
             practicing adequate birth control.

          9. Malignant tumour (past history or concurrent disease)(except carcinoma in situ or
             basalioma in remission)

         10. History of bone harvesting on iliac crest contraindicating new iliac crest bone graft
             harvesting or bone marrow collection

         11. Insulin dependent diabetes

         12. Any evidence (confirmed by PCR) of active infection with HIV, Hepatitis B or Hepatitis
             C infection

         13. Any evidence of Syphilis

         14. Known allergies to products involved in the production process of MSC

         15. Corticoid or immunosuppressive therapy more than one week in the three months prior to
             study inclusion

         16. Autoimmune inflammatory disease

         17. Current treatment by biphosphonates not stopped three months prior to study inclusion

         18. Impossibility to meet at the appointments for the follow up

         19. Participation in another therapeutic trial in the previous 3 months

         20. Second non-union in case of bilateral or multiple non-unions (only one non-union per
             patient will be included in the trial)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enrique Gomez-Barrena, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>UAM</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Enrique Gomez-Barrena, Prof</last_name>
    <phone>+34912071204</phone>
    <email>enrique.gomezbarrena@uam.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cristina Avendano-Sola, MD</last_name>
    <phone>+34911916479</phone>
    <email>cristina.avendano@uam.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stéphane Descamps, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Orthopaedic Surgery, Hospital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Charles-Henri Flouzat -Lachaniette, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Orthopaedic Surgery CHU Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Department of Orthopaedic Surgery, CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dennis Waast, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Orthopaedic Surgery Toulouse University Hospital</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nicolas Reina, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Orthopaedic Surgery, CHU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Philippe Rosset, Prof. Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt, Department of Trauma, Hand and Reconstructive Surgery</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ingo Marzi, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg, Klinik für Orthopädie und Unfallchirurgie</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>J Bayer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum München</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christian Ehrnthaller, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitätsklinikumTübingen</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Department of Orthopaedic Trauma, University of Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>8907581</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Markus Huber-Lang, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Ortopedico Rizzoli, SSD Fisiopatologia Ortopedica e Medicina Rigenerativa</name>
      <address>
        <city>Bologna</city>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nicola Baldini, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arienda Spedali Civili di Brescia II Ortopedia e Traumatologia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ugo Pazzaglia, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS AO Universitaria San Martino - IST</name>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Istituto Ortopedico Galeazzi, Chirugia dell´Anca l</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Luigi Zagra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero- Universitaria di Modena, Reparto di Ortopedia e Traumatologia</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Fabio Cattani, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Universitaria Ospedaliera di Pisa- II, Clinica di Ortopedia e Traumatologia</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Rodolfo Capanna, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. Puerta de Hierro-Majadahonda, Servicio de Cirugía Ortopédica y Traumatología</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pablo de la Cuadra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínica San Carlos, Servicio de Cirugía Ortopédica y Traumatología</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fernando Marco, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. 12 de Octubre, Servicio de Cirugía Ortopédica y Traumatología</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pedro Caba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. Gregorio Marañon, Servicio de Cirugía Ortopédica y Traumatología</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Javier Vaquero, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. La Princesa, Servicio de CirugíaOrtopédica y Traumatología</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jose Cordero, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Basilio de la Torre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Servicio de Cirugía Ortopédica y Traumatología &quot;A&quot;, Hospital La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Enrique Gomez-Barrena, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://orthounion.eu</url>
    <description>Webpage of the Orthounion Study</description>
  </link>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>October 25, 2017</study_first_submitted>
  <study_first_submitted_qc>October 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2017</study_first_posted>
  <last_update_submitted>September 19, 2019</last_update_submitted>
  <last_update_submitted_qc>September 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Autonoma de Madrid</investigator_affiliation>
    <investigator_full_name>Prof Enrique Gomez-Barrena</investigator_full_name>
    <investigator_title>Full Professor and Chair of orthopaedic surgery</investigator_title>
  </responsible_party>
  <keyword>Non-union</keyword>
  <keyword>Advanced therapies</keyword>
  <keyword>Mesenchymal stem cells</keyword>
  <keyword>Long bone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Ununited</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

